|
|
||||||||
HIGHLIGHTED TOPICS
Oxygen Sensing in Health and Disease
1Division of Neonatology, Department of Pediatrics, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287-3200; 2Department of Physiology and Biophysics, College of Medicine, Howard University, Washington, DC 20059; and 3Department of Biology, School of Computer, Mathematical and Natural Sciences, Morgan State University, Baltimore, Maryland 21251
Submitted 22 August 2003 ; accepted in final form 17 September 2003
| ABSTRACT |
|---|
|
|
|---|
peripheral arterial chemoreceptors; neurotransmitters; glomus cells; development; choline acetyltransferase; vesicular acetylcholine transporter
In the healthy fetus, peripheral arterial chemoreceptors do not significantly contribute to fetal breathing, nor is their activity necessary for establishing rhythmic breathing at birth (24) irrespective of the level of hypoxia, which is
25 Torr. However, multiple studies (5, 8, 20), in numerous mammalian models, support a role for peripheral arterial chemoreceptors in contributing to stable ventilation at a critical period of development, during early postnatal life, which establishes rhythmogenesis that is sustained throughout life. After the resetting of the peripheral arterial chemoreceptor to a higher O2 tension, after birth there is a gradual increase in hypoxic chemosensitivity of these chemoreceptors, with early postnatal maturation, in essentially all mammalian species (1, 4, 25). Asphyxial apnea associated with upper airway obstruction is thought to occur in infants at risk for sudden infant death. Activation of peripheral arterial chemoreceptors decreases the time to arousal and reestablishes airway patency in immature and mature models during asphyxial apnea. Thus understanding of cellular mechanisms involved in maturation of peripheral arterial chemoreceptor function is key.
To date, it is not known how O2 tension is sensed by type I cells. It is, however, well established that hypoxia causes type I cells to depolarize and release transmitters, which bind autoreceptors expressed by type I cells or heteroreceptors on nerve terminals innervating type I cells (16). The predominant excitatory transmitter synthesized and released by type I cells, in response to hypoxia, is still a matter of debate (16). Earlier work led to the cholinergic hypothesis that acetylcholine (ACh) perhaps was the major excitatory neurotransmitter involved in hypoxic chemotransmission (9, 19). Subsequent studies either were unable to substantiate or even refuted this hypothesis (7, 29, 34). Recent evidence, predominately from physiological and pharmacological studies performed in the adult cat (11) and immunohistochemical and electrophysiological studies in primary culture of rat type I cells (32), has brought about a resurgence of the excitatory role of ACh on peripheral chemoreceptor activation in response to hypoxic exposure (10, 12).
Choline acetyltransferase (ChAT) is the rate-limiting enzyme for the synthesis of ACh, and the vesicular ACh transporter (VAChT) transports ACh into synaptic vesicles. Expression of ChAT and VAChT mRNA and protein serve as definitive markers for cholinergic neurons in the periphery and in the central nervous system (CNS) (43). In this study, we hypothesized that ChAT and VAChT mRNA levels would increase with postnatal maturation and that hypoxia-induced upregulation of these mRNAs would be greatest in the more mature animals. Semiquantitative in situ hybridization histochemistry (ISHH) and immunohistochemistry (IH) were used to localize mRNAs and protein, respectively, to specific neurons and cells in peripheral arterial chemoreceptors. A preliminary report of this work has been presented and referred to in a recently published review article by Gauda (14).
| METHODS |
|---|
|
|
|---|
ISHH. Tissue blocs were cut in 12-µm sections on a cryostat and thaw-mounted onto gelatin-chrome alum-subbed slides. Slide-mounted sections were fixed with 4% paraformaldehyde, acetylated in fresh 0.25% acetic anhydride in 0.1 M triethanolamine, dehydrated in an ascending series of alcohols, delipidated in chloroform, and rehydrated in a descending series of alcohols. Slides were air dried and then stored at -20°C.
Because multiple splice variants exist for ChAT and VAChT, we used clones that contained the entire coding region of the rat ChAT (23) and VAChT (2, 37) genes. (These clones were kindly provided by Dr. Hidemi Misawa, Tokyo Metropolitan Institute for Neuroscience, Tokyo, Japan). The cDNAs were subcloned into Bluescript (Stratagene) plasmids to allow for in vitro transcription to generate sense and antisense ribonucleotide probes. Specificity of the sense and antisense digoxigeninin-labeled ribonucleotide probes has been well characterized (22, 23). In our experiments, probes were labeled with 35S-labeled UTP to increase the sensitivity of the probe to detect very low levels of mRNAs, and ISHH was performed, as previously described (15). Serial sections were also hybridized with antisense ribonulceotide probe for TH, the rate-limiting enzyme in catecholamine synthesis, complementary to base pairs 1,1201,488 of the rat cDNA (18). Before overnight hybridization at 55°C, sections were treated with proteinase K (2.5 µg/ml; Fisher Biotech, Fairlawn, NJ) for 5 min and rinsed with phosphate-buffered saline. As outlined in Gauda et al. (15), after hybridization, the slides were rinsed, treated with RNAse A (20 mg/ml; Sigma Chemical, St. Louis, MO), washed at 60°C in x0.2 saline-sodium citrate buffer (Sigma Chemical), rinsed in deionized water, and air dried. Slides were then dipped in Kodak photographic emulsion, dried, and exposed in the dark at -20°C for 810 wk. Postexposure slides were thawed, developed with Dektol (Eastman Kodak, Kodak, NY), fixed in Kodak Fixer, rinsed, and counterstained with thionin, and coverslips were applied with Per-mount.
To verify the specificity of the ribonucleotide probes by ISHH, rat coronal brain sections (Bregma 0.70, Paxinos and Watson) were hybridized, exposed, and developed simultaneously with the experimental slides. Control slides exhibited previously established patterns of expression for ChAT and VAChT mRNA, and protein in striatopallidal neurons (2123). In addition, the pattern of ChAT and VAChT gene expression differed in the CB, NG-PG-JG complex, and the SCG, further demonstrating probe specificity.
IH. Tissue sections were processed for VAChT and TH immunoreactivity (IR) alone or were sequentially processed for VAChT and then TH protein in the CB, NG-PG-JG complex, and the SCG. All tissue sections of the entire CB, NG-PG-JG complex, and the SCG from animals at 4, 8, 1315, and 28 postnatal days (n = 3 at each age) were processed for VAChT IR alone or were double-labeled to detect VAChT and TH IR. Primary and secondary antibody combinations for VAChT protein visualization included 1) VAChT goat polyclonal IgG directed to the COOH-terminal of rat VAChT (1:100 dilution) and 2) mouse anti-goat conjugated to alkaline phosphatase (1:200 dilution). Both primary and secondary antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Primary and secondary antibody combination for TH protein visualization included 1) mouse anti-TH IgG2a monoclonal antibody (1:500 dilution; Chemicon International, Temecula, CA) and 2) biotinylated rat anti-mouse IgG2a (1:100; BD Biosciences Pharmigen, San Diego, CA). All antibodies were diluted in 0.3% Triton X-100 in Tris-buffered saline (TBS). All incubations with primary and secondary antibodies were performed in a humid Plexiglas container.
Single-labeling IH to detect VAChT. Tissue sections were cut, thaw mounted onto gelatin-chrome alum-subbed slides, fixed in 4% paraformaldehyde, and washed three times for 5 min each in 1 M TBS (pH 7.4). The slides were then incubated in ice-cold acetone for 10 min and subsequently rinsed three times with TBS. Nonspecific binding was blocked by incubation in 3% BSA containing 0.1% Triton X-100 in TBS for 30 min. Slides were incubated with the anti-VAChT antibody overnight at room temperature, washed with TBS, incubated with mouse anti-goat-alkaline phosphatase secondary antibody for 2 h at room temperature, washed with TBS, placed in visualization buffer containing 100 mM Tris·HCl, 100 mM NaCl, 50 mM MgCl2, 0.34 mg/ml nitro blue tetrazolium, 0.18 mg/ml 5-bromo-4-chloro-3-indolyl-phosphate (4-toluidine salt), and 5 mM levisomole for 2 h. VAChT expression was visualized as a dark blue reaction product. For single-labeling IH, the reaction was stopped in water, and coverslips were applied with an aqueous based mounting media.
Double-labeling IH to detect VAChT and TH IR. Additional slides were processed for both VAChT and TH IR. After VAChT-IR visualization, the slides were washed three times in TBS, incubated in 3% hydrogen peroxide in TBS for 10 min, and incubated overnight with the primary antibody (anti-TH) at 4°C. Tissues were washed followed by incubation with biotinylated rat anti-mouse IgG2a secondary antibody at room temperature. After the slides were washed in TBS, they were incubated in freshly prepared streptavidin-horseradish peroxidase reaction mixture for 4 min followed by several washes in TBS. TH IR was visualized by incubating the slides in aminoethyl carbazole substrate (Zymed, San Francisco, CA) for 10 min. TH IR was visualized as a red reaction product. After visualization of the TH IR, the slides were rinsed with distilled water, and coverslips were applied with a water-soluble mounting media. Control slides were included and processed in the same manner as experimental slides except the primary antibodies were omitted or the antibody was preabsorded with blocking peptide. Specifically, VAChT antibody was preabsorbed with the blocking peptide (Santa Cruz Biotechnology) in a ratio of 1:100 (antibody to blocking peptide) overnight before being applied to tissue sections and further processed for IH.
Data analysis. Qualitative and semiquantiative analysis of the data were performed. The pattern of expression for ChAT and VAChT mRNA, and IR for VAChT protein was determined in the CB, NG-JG-PG complex, and the SCG during the first 25 days of postnatal development. The effect of hypoxic exposure on ChAT and VAChT mRNA expression was determined by semiquantitative analysis of silver grains in animals exposed to air or hypoxic gas. Silver grains, generated by 35S in the emulsion, were analyzed by using a Nikon microscope and Macintosh image analysis program (National Institutes of Health Image). Darkfield images were captured and digitized at x400 and semiquantified by using silver grains representing VAChT mRNA expression in the NG-PG-JG complex from animals exposed to air or hypoxia at P4 and P14. The number of silver grains was obtained for 10 ganglion cells per section of the NG-PG-JG complex with five to seven tissue sections analyzed per animal. The mean number of silver grains per ganglion cell per animal was determined, and comparisons were made between P4 and P14 animals exposed to air or hypoxia by using the Student's unpaired t-test with a Bonferroni correction for multiple comparisons. Thus significance was accepted at P < 0.025. Comparisons (qualitative and semiquantitative) were only made between data obtained from slides that were processed for ISHH, hybridized, exposed, and developed together under the same conditions.
| RESULTS |
|---|
|
|
|---|
|
|
|
Comparison of ChAT and VAChT mRNA expression profile with that of TH mRNA expression. Although ChAT and VAChT mRNA expression were not seen within the CB, this was not the case for TH mRNA expression. For example, a representative series of photomicrographs, showing the expression of ChAT, VAChT, and TH mRNAs on 12-µm serial sections of the CB and NG-PG-JG complex from one animal at P4 after 4 h of exposure to hypoxia, is shown in Fig. 4. Serial sections of the CB showed essentially undetectable levels of ChAT (Fig. 4A) and VAChT (Fig. 4B) mRNAs, whereas TH mRNA expression was abundantly expressed in the CB (Fig. 4C). Low levels of ChAT mRNA expression (slightly above background) were seen in a few cells, moderate levels of VAChT mRNA expression were seen in numerous cells, and high levels of TH mRNA expression were seen in a moderate number of cells on serial sections of the NG-PG-JG complex.
|
Pattern of VAChT-IR in the CB and SCG during postnatal development. The distribution of VAChT IR dectected by IH was similar to that of the distribution of the mRNA in the tissues from animals between P4 and P28. Intense VAChT IR was detected in cells on the periphery of the CB, which are most likely autonomic microganglion cells (Fig. 5, AD). On average, three to six microganglion cells per animal were seen within and on the periphery of the CB. This number was similar in animals at P4 and P14. Within the CB, the distribution of VAChT expression was linear and appeared to surround clusters of type I cell as exemplified in the photomicrograph from an animal at P15 (Fig. 5, E and F). Numerous cells, intensely positive for VAChT IR, were seen in larger nerves from animals at each postnatal age, as shown in Fig. 6. Cells intensely positive for VAChT were seen in nerve fibers next to the CB (Fig. 6, A and B) and large nerve fibers within the tissue bloc (Fig. 6, C and D). VAChT IR appeared as an intricate latticework surrounding the ganglion cells throughout the SCG (Fig. 6, A and C).
|
|
Comparison of the pattern of VAChT IR and TH IR in the SCG, NG-PG-JG complex, and CB by using double-labeling IH. Double-labeled IH was performed to determine whether VAChT and TH IRs are colocalized. Essentially all ganglion cells in the SCG were intensely positive for TH IR, whereas preganglonic nerve fibers, innervating the SCG, were intensely positive for VAChT IR, (Fig. 7A). Ganglion cells in the NG-PG-JG complex were positive for VAChT IR; however, VAChT IR ganglion cells were larger than those ganglion cells that were positive for TH IR in the NG-PG-JG complex (Fig. 7B), and the two chromogens were not colocalized. As shown in Fig. 8, microganglion cells, in nerve fibers and on the periphery of the CB, were intensely positive for VAChT IR (Fig. 8, A and B), which is identical to the pattern of expression seen in the IH experiments that detected VAChT IR alone. VAChT IR was not colocalized with TH IR within the CB; however, VAChT IR nerve fibers were closely juxtaposed to TH IR cells within the CB (Fig. 8, B and D), and microganglion cells were embedded within the CB (Fig. 8, CF). Small clusters of microganglion cells were seen adjacent to clusters of TH IR cells, which are presumably clusters of type I cells (Fig. 8, E and F). Control slides, processed without the addition of primary antibody for TH and VAChT, were negative for IR, whereas control slides in which the antibody was preabsorbed with the antigen (1:100 antigen-to-antibody ratio) overnight before application to the slides showed faint immunostaining for VAChT.
|
|
| DISCUSSION |
|---|
|
|
|---|
The results of the present study indicate that ACh found within the CB originates mainly from nerve fibers and autonomic microganglion cells embedded within the CB and not in type I cells. Immunostaining of entire CBs from multiple animals allowed us to discern single and sometimes multiple microganglion cells within fibers juxtaposed to distinct clusters of type I cells. These microganglia could account for small amounts of ACh, which were detected by HPLC in in vitro preparations of the CB, as reported by Fitzgerald et al. (13). Also, our ISHH confirmed low levels of ChAT mRNA within these cells, suggesting their capacity to synthesize ACh. In addition, our data support the results of Schütz et al. (35), who showed that the expression of ChAT is far less abundant than VAChT mRNAs in the peripheral nervous system, whereas ChAT and VAChT mRNAs and IR are comparable in the CNS.
Multiple mRNA splice variants exist for the ChAT and VAChT genes. Each of these splice variants occurs within the noncoding regions of the genes and do not affect the coding region. Thus the cDNA that we used for in vitro transcription contained the entire coding region for both of the genes. Nevertheless, a new alternative splice variant and subsequent protein product have been identified for ChAT, which appears to be expressed preferentially in the periphery (pChAT). Tooyama and Kimura (36) cloned pChAT from the rat and reported that the gene product lacked exons 69 of the ChAT gene. Rabbit antiserum raised against pChAT has been developed using the 41-amino acid polypeptide that spans the splice joint between exons 5 and 10 (36). The expression of pChAT mRNA and protein was preferentially localized to cholinergic neurons in the periphery vs. those in the CNS (30, 31, 36). Thus the low level of mRNA expression that we detected in the NG-PG-JG complex and perhaps the absence of ChAT expression in type I cells could be explained by the existence of an alternative splice variant that our probes could not detect. On the other hand, a splice variant for VAChT that is uniquely expressed in the periphery, to our knowledge, has not been described. Furthermore, VAChT IR is frequently used to detect cholinergic neurons in the periphery and in the CNS (42). The results of this present study agree with those of Schütz et al. (35), who indicated that VAChT IR is not expressed in type I cells within the CB but that VAChT IR is present within microganglion cells and nerve terminals of the CB in newborn and adult rats. We are aware, however, that the possibility exists that a splice variant of the VAChT gene could be expressed in type I cells, which differs from the splice variant for VAChT that is expressed in the microganglion cells juxataposed to clusters of type I cells and found in the pre- and postganglionic nerve fibers in the SCG and CB, respectively.
We also observed strong VAChT IR in terminal nerve fibers surrounding clusters of type I cells, which are most likely the postganglionic parasympathetic fibers previously shown by detailed morphological studies performed by McDonald (28) and Wang et al. (39) in the rat CB. Wang et al. also described ganglion cells on the periphery of the rat CB, which coexpress IR for nitric oxide synthase and ChAT; however, IR for ChAT and nitric oxide synthase was not detected in type I cells. Species differences, however, may exist. In earlier studies, Wang et al. (40, 41) reported the presence of ChAT IR localized to type I cells in the carotid bodies of the cat and rabbit. Alternatively, another source of ACh in the CB of the cat could be microganglion cells, since autonomic ganglion cells in the cat CB have also been described by De Castro et al. (see Ref. 28). Our data suggest that microganglion cells in the rat are likely to be a rich source of ACh in the CB. It seems plausible that microganglion cells and cholinergic fibers release ACh in response to hypoxia, which could account for the increase in ACh detected in the perfusate of CBs exposed to hypoxia in vitro (13).
Although the expression of VAChT in peripheral arterial chemoreceptors does not appear to be transcriptionally regulated by subacute (4 h) hypoxic exposure, expression in NGPG-JG complex does appear to be regulated by development. Similar to the observations of others (35), we found a significant reduction in VAChT mRNA expression in the NG-PG-JG complex during postnatal maturation. Although our study was not designed to determine the mechanism for this reduction during development, several plausible explanations exist. Bone morphogenetic proteins (BMPs) are members of the transforming growth factor-
superfamily, which are involved in growth and differentiation (27). BMPs specifically promote survival and phenotypic maturation of neurons in the peripheral nervous system and CNS (33, 38). VAChT and ChAT are both transcriptionally upregulated by BMP-9, an important inducer of cholinergic phenotype in the CNS (26). In addition, retinoic acid, cAMP, leukemic inhibitory factor/ciliary neurotrophic factor have all been shown to induce and upregulate VAChT and ChAT mRNAs in cholinergic neurons in culture (3). Either a reduction in BMP-9 and leukemic inhibitory factor/ciliary neurotrophic factor or changes in receptor levels for these ligands on NG-PG-JG ganglion cells during development could result in downregulation of VAChT mRNA expression during maturation. Alternatively, although not addressed by our study, a reduction in the number of cholinergic-expressing cells in the NG-PG-JG complex may occur via programmed cell death during early postnatal maturation in the newborn rat.
In conclusion, the results of this study on the developing rat CB, utilizing semiquantitative ISHH and IH to detect cholinergic traits at the message and protein levels, respectively, indicate that autonomic ganglion cells and cholinergic nerve terminals innervating the CB are a major source of ACh. Furthermore, under the present experimental conditions, 4 h of hypoxic exposure does not affect the levels of VAChT and ChAT mRNA expression in the CB or in ganglion cells within the NG-PG-JG complex. However, these findings do not definitively exclude possible contributions from type I cells on cholinergic transmission in the peripheral arterial chemoreceptors in other species (10, 12) or dissociated carotid bodies in culture (32).
| ACKNOWLEDGMENTS |
|---|
|
|
|---|
GRANTS
This study was supported by National Institutes of Health Grants RO1 DA-13940 (to E. B. Gauda and G. L. McLemore) and U54 NS-39407 (to S. M. Johnson).
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
signal transduction. Annu Rev Biochem 67: 753-791, 1998.
This article has been cited by other articles:
![]() |
S. V. Conde, A. Obeso, and C. Gonzalez Low glucose effects on rat carotid body chemoreceptor cells' secretory responses and action potential frequency in the carotid sinus nerve J. Physiol., December 15, 2007; 585(3): 721 - 730. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhang and C. A. Nurse CO2/pH Chemosensory Signaling in Co-Cultures of Rat Carotid Body Receptors and Petrosal Neurons: Role of ATP and ACh J Neurophysiol, December 1, 2004; 92(6): 3433 - 3445. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Sieck Commentary J Appl Physiol, January 1, 2004; 96(1): 375 - 375. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |